Portola Group’s Novo Nordisk NVO Stock Holding History

Portola Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-11,600	Closed	-$268K	–	92
2014 Q2	$268K	Hold	11,600	–	–	0.22%	78
2014 Q1	$265K	Buy	+11,600	New	+$247K	0.24%	66

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Portola Group's NVO Position: Q3 2014 in Review

Portola Group sold out of Novo Nordisk (NVO) in Q3 2014, closing a stake of 11,600 shares — an estimated $268K sold.

Portola Group first reported a position in NVO in Q1 2014 and held it in 2 quarters. The position peaked at $268K in Q2 2014. 469 funds tracked by Wall St. Rank hold NVO as of Q3 2014.

Portola Group reported no remaining Novo Nordisk position as of Q3 2014 after selling out during the quarter.
Portola Group sold 11,600 Novo Nordisk shares in Q3 2014, an estimated $268K.
Portola Group first reported a position in Novo Nordisk in Q1 2014 and held it in 2 quarters.
Portola Group's Novo Nordisk position peaked at $268K in Q2 2014.
469 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2014.

Based on Portola Group's 13F filing for Q3 2014, filed 2 Mar 2015.